May 03, 2016
Weil is advising IMS Health Holdings, Inc., a leading global information and technology services company, in its definitive all-stock merger of equals with Quintiles Transnational Holdings Inc., the world’s largest provider of product development and integrated healthcare services. The equity market capitalization of the combined company is more than $17.6 billion. The merged company will be named Quintiles IMS Holdings, Inc. The deal is expected to close in the second half of 2016, subject to customary closing conditions.
The Weil team advising IMS is led by Corporate Chairman Michael Aiello and includes M&A partner Matthew Gilroy; Banking & Finance head Douglas Urquhart; Capital Markets partner Frank Adams; Technology & IP Transactions partner Charan Sandhu; Executive Compensation & Benefits head Paul Wessel; M&A associates Christina De Vuono, Maxwell Copelan, Sean Devaney, Dianna Lee, Megan Briskman (not yet admitted to practice) and Francesca Cohen (not yet admitted to practice); Banking & Finance associates Brian Drozda, Sarah Davis and Suhan Shim; Capital Markets associates Anthony Mascarenhas, Raghav Thapar and Alla Khabinskaya (not yet admitted to practice); Technology & IP Transactions associates Caroline Geiger and Mary Lentowski; Tax associate Joseph Reich; and Executive Compensation & Benefits associates Amanda Rosenblum and Franny Glick.